Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs268

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr8:19956018 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
A>G
Variation Type
SNV Single Nucleotide Variation
Frequency
G=0.011043 (2923/264690, TOPMED)
G=0.012780 (3212/251336, GnomAD_exome)
G=0.016273 (3560/218762, ALFA) (+ 19 more)
G=0.013274 (1862/140276, GnomAD)
G=0.013363 (1622/121378, ExAC)
G=0.00497 (391/78696, PAGE_STUDY)
G=0.00004 (1/28258, 14KJPN)
G=0.00006 (1/16760, 8.3KJPN)
G=0.0047 (30/6404, 1000G_30x)
G=0.0052 (26/5008, 1000G)
G=0.0239 (107/4480, Estonian)
G=0.0187 (72/3854, ALSPAC)
G=0.0200 (74/3708, TWINSUK)
G=0.030 (30/998, GoNL)
G=0.006 (4/708, HapMap)
G=0.028 (17/600, NorthernSweden)
G=0.013 (7/534, MGP)
G=0.013 (4/304, FINRISK)
G=0.03 (2/70, Ancient Sardinia)
G=0.05 (2/40, GENOME_DK)
A=0.5 (1/2, SGDP_PRJ)
G=0.5 (1/2, SGDP_PRJ)
Clinical Significance
Reported in ClinVar
Gene : Consequence
LPL : Missense Variant
Publications
29 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20231103111315
Population Group Sample Size Ref Allele Alt Allele Ref HMOZ Alt HMOZ HTRZ HWEP
Total Global 235134 A=0.983852 G=0.016148 0.967976 0.000272 0.031752 0
European Sub 197850 A=0.982325 G=0.017675 0.964953 0.000303 0.034743 0
African Sub 10974 A=0.99608 G=0.00392 0.992163 0.0 0.007837 0
African Others Sub 394 A=0.997 G=0.003 0.994924 0.0 0.005076 0
African American Sub 10580 A=0.99603 G=0.00397 0.99206 0.0 0.00794 0
Asian Sub 6406 A=1.0000 G=0.0000 1.0 0.0 0.0 N/A
East Asian Sub 4556 A=1.0000 G=0.0000 1.0 0.0 0.0 N/A
Other Asian Sub 1850 A=1.0000 G=0.0000 1.0 0.0 0.0 N/A
Latin American 1 Sub 818 A=0.989 G=0.011 0.977995 0.0 0.022005 0
Latin American 2 Sub 1028 A=0.9893 G=0.0107 0.978599 0.0 0.021401 0
South Asian Sub 280 A=0.993 G=0.007 0.985714 0.0 0.014286 0
Other Sub 17778 A=0.98678 G=0.01322 0.973788 0.000225 0.025987 0


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
TopMed Global Study-wide 264690 A=0.988957 G=0.011043
gnomAD - Exomes Global Study-wide 251336 A=0.987220 G=0.012780
gnomAD - Exomes European Sub 135278 A=0.980167 G=0.019833
gnomAD - Exomes Asian Sub 49010 A=0.99884 G=0.00116
gnomAD - Exomes American Sub 34582 A=0.99326 G=0.00674
gnomAD - Exomes African Sub 16256 A=0.99668 G=0.00332
gnomAD - Exomes Ashkenazi Jewish Sub 10080 A=0.98938 G=0.01062
gnomAD - Exomes Other Sub 6130 A=0.9873 G=0.0127
Allele Frequency Aggregator Total Global 218762 A=0.983727 G=0.016273
Allele Frequency Aggregator European Sub 187748 A=0.982418 G=0.017582
Allele Frequency Aggregator Other Sub 16346 A=0.98721 G=0.01279
Allele Frequency Aggregator Asian Sub 6406 A=1.0000 G=0.0000
Allele Frequency Aggregator African Sub 6136 A=0.9954 G=0.0046
Allele Frequency Aggregator Latin American 2 Sub 1028 A=0.9893 G=0.0107
Allele Frequency Aggregator Latin American 1 Sub 818 A=0.989 G=0.011
Allele Frequency Aggregator South Asian Sub 280 A=0.993 G=0.007
gnomAD - Genomes Global Study-wide 140276 A=0.986726 G=0.013274
gnomAD - Genomes European Sub 75956 A=0.98092 G=0.01908
gnomAD - Genomes African Sub 42050 A=0.99703 G=0.00297
gnomAD - Genomes American Sub 13660 A=0.98272 G=0.01728
gnomAD - Genomes Ashkenazi Jewish Sub 3322 A=0.9898 G=0.0102
gnomAD - Genomes East Asian Sub 3134 A=1.0000 G=0.0000
gnomAD - Genomes Other Sub 2154 A=0.9916 G=0.0084
ExAC Global Study-wide 121378 A=0.986637 G=0.013363
ExAC Europe Sub 73344 A=0.97971 G=0.02029
ExAC Asian Sub 25164 A=0.99873 G=0.00127
ExAC American Sub 11558 A=0.99515 G=0.00485
ExAC African Sub 10406 A=0.99721 G=0.00279
ExAC Other Sub 906 A=0.981 G=0.019
The PAGE Study Global Study-wide 78696 A=0.99503 G=0.00497
The PAGE Study AfricanAmerican Sub 32514 A=0.99677 G=0.00323
The PAGE Study Mexican Sub 10810 A=0.99445 G=0.00555
The PAGE Study Asian Sub 8316 A=0.9998 G=0.0002
The PAGE Study PuertoRican Sub 7916 A=0.9893 G=0.0107
The PAGE Study NativeHawaiian Sub 4534 A=0.9971 G=0.0029
The PAGE Study Cuban Sub 4230 A=0.9901 G=0.0099
The PAGE Study Dominican Sub 3828 A=0.9901 G=0.0099
The PAGE Study CentralAmerican Sub 2450 A=0.9947 G=0.0053
The PAGE Study SouthAmerican Sub 1982 A=0.9909 G=0.0091
The PAGE Study NativeAmerican Sub 1260 A=0.9897 G=0.0103
The PAGE Study SouthAsian Sub 856 A=0.998 G=0.002
14KJPN JAPANESE Study-wide 28258 A=0.99996 G=0.00004
8.3KJPN JAPANESE Study-wide 16760 A=0.99994 G=0.00006
1000Genomes_30x Global Study-wide 6404 A=0.9953 G=0.0047
1000Genomes_30x African Sub 1786 A=0.9994 G=0.0006
1000Genomes_30x Europe Sub 1266 A=0.9882 G=0.0118
1000Genomes_30x South Asian Sub 1202 A=0.9975 G=0.0025
1000Genomes_30x East Asian Sub 1170 A=1.0000 G=0.0000
1000Genomes_30x American Sub 980 A=0.989 G=0.011
1000Genomes Global Study-wide 5008 A=0.9948 G=0.0052
1000Genomes African Sub 1322 A=0.9992 G=0.0008
1000Genomes East Asian Sub 1008 A=1.0000 G=0.0000
1000Genomes Europe Sub 1006 A=0.9861 G=0.0139
1000Genomes South Asian Sub 978 A=0.997 G=0.003
1000Genomes American Sub 694 A=0.988 G=0.012
Genetic variation in the Estonian population Estonian Study-wide 4480 A=0.9761 G=0.0239
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 A=0.9813 G=0.0187
UK 10K study - Twins TWIN COHORT Study-wide 3708 A=0.9800 G=0.0200
Genome of the Netherlands Release 5 Genome of the Netherlands Study-wide 998 A=0.970 G=0.030
HapMap Global Study-wide 708 A=0.994 G=0.006
HapMap American Sub 324 A=0.994 G=0.006
HapMap Europe Sub 176 A=0.989 G=0.011
HapMap African Sub 120 A=1.000 G=0.000
HapMap Asian Sub 88 A=1.00 G=0.00
Northern Sweden ACPOP Study-wide 600 A=0.972 G=0.028
Medical Genome Project healthy controls from Spanish population Spanish controls Study-wide 534 A=0.987 G=0.013
FINRISK Finnish from FINRISK project Study-wide 304 A=0.987 G=0.013
Ancient Sardinia genome-wide 1240k capture data generation and analysis Global Study-wide 70 A=0.97 G=0.03
The Danish reference pan genome Danish Study-wide 40 A=0.95 G=0.05
SGDP_PRJ Global Study-wide 2 A=0.5 G=0.5
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 8 NC_000008.11:g.19956018A>G
GRCh37.p13 chr 8 NC_000008.10:g.19813529A>G
LPL RefSeqGene (LRG_1298) NG_008855.2:g.59302A>G
Gene: LPL, lipoprotein lipase (plus strand)
Molecule type Change Amino acid[Codon] SO Term
LPL transcript NM_000237.3:c.953A>G N [AAT] > S [AGT] Coding Sequence Variant
lipoprotein lipase precursor NP_000228.1:p.Asn318Ser N (Asn) > S (Ser) Missense Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: G (allele ID: 16589 )
ClinVar Accession Disease Names Clinical Significance
RCV000001615.6 Hyperlipidemia, familial combined, LPL related Pathogenic
RCV000781944.1 Hyperlipidemia, familial combined, susceptibility to Risk-Factor
RCV000988041.8 Hyperlipoproteinemia, type I Uncertain-Significance
RCV001356263.7 not provided Conflicting-Interpretations-Of-Pathogenicity
RCV002222335.1 not specified Benign
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement A= G
GRCh38.p14 chr 8 NC_000008.11:g.19956018= NC_000008.11:g.19956018A>G
GRCh37.p13 chr 8 NC_000008.10:g.19813529= NC_000008.10:g.19813529A>G
LPL RefSeqGene (LRG_1298) NG_008855.2:g.59302= NG_008855.2:g.59302A>G
LPL transcript NM_000237.3:c.953= NM_000237.3:c.953A>G
LPL transcript NM_000237.2:c.953= NM_000237.2:c.953A>G
lipoprotein lipase precursor NP_000228.1:p.Asn318= NP_000228.1:p.Asn318Ser
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

100 SubSNP, 21 Frequency, 5 ClinVar submissions
No Submitter Submission ID Date (Build)
1 DEBNICK ss268 Sep 19, 2000 (36)
2 PERLEGEN ss23712753 Sep 20, 2004 (123)
3 MGC_GENOME_DIFF ss28505039 Sep 24, 2004 (126)
4 APPLERA_GI ss48420135 Mar 11, 2006 (126)
5 PERLEGEN ss69043148 May 17, 2007 (127)
6 AFFY ss74819581 Aug 16, 2007 (128)
7 ILLUMINA ss74905524 Dec 06, 2007 (129)
8 BCMHGSC_JDW ss93851529 Mar 25, 2008 (129)
9 ENSEMBL ss143320833 Dec 01, 2009 (131)
10 ILLUMINA ss173427532 Jul 04, 2010 (132)
11 PAGE_STUDY ss181341869 Jul 04, 2010 (132)
12 BCM-HGSC-SUB ss206439351 Jul 04, 2010 (132)
13 1000GENOMES ss217321419 Jul 14, 2010 (132)
14 1000GENOMES ss217397623 Jul 14, 2010 (132)
15 1000GENOMES ss217418282 Jul 14, 2010 (132)
16 OMICIA ss244238715 May 27, 2010 (132)
17 ILLUMINA ss244291490 Jul 04, 2010 (132)
18 OMIM-CURATED-RECORDS ss252841599 Aug 10, 2010 (132)
19 1000GENOMES ss334734988 May 09, 2011 (134)
20 NHLBI-ESP ss342253784 May 09, 2011 (134)
21 1000GENOMES ss490960919 May 04, 2012 (137)
22 EXOME_CHIP ss491410891 May 04, 2012 (137)
23 CLINSEQ_SNP ss491921986 May 04, 2012 (137)
24 ILLUMINA ss537115398 Sep 08, 2015 (146)
25 ILLUMINA ss780867933 Sep 08, 2015 (146)
26 ILLUMINA ss783552867 Sep 08, 2015 (146)
27 EVA-GONL ss985272617 Aug 21, 2014 (142)
28 1000GENOMES ss1328915147 Aug 21, 2014 (142)
29 EVA_GENOME_DK ss1582593752 Apr 01, 2015 (144)
30 EVA_FINRISK ss1584057346 Apr 01, 2015 (144)
31 EVA_DECODE ss1594862271 Apr 01, 2015 (144)
32 EVA_UK10K_ALSPAC ss1620133702 Apr 01, 2015 (144)
33 EVA_UK10K_TWINSUK ss1663127735 Apr 01, 2015 (144)
34 EVA_EXAC ss1689111573 Apr 01, 2015 (144)
35 EVA_MGP ss1711194704 Apr 01, 2015 (144)
36 EVA_SVP ss1713021090 Apr 01, 2015 (144)
37 ILLUMINA ss1752723237 Sep 08, 2015 (146)
38 ILLUMINA ss1917826322 Feb 12, 2016 (147)
39 ILLUMINA ss1946231540 Feb 12, 2016 (147)
40 ILLUMINA ss1946231541 Feb 12, 2016 (147)
41 ILLUMINA ss1959093877 Feb 12, 2016 (147)
42 ILLUMINA ss1959093878 Feb 12, 2016 (147)
43 JJLAB ss2024980549 Sep 14, 2016 (149)
44 HUMAN_LONGEVITY ss2301287943 Dec 20, 2016 (150)
45 ILLUMINA ss2634720445 Nov 08, 2017 (151)
46 ILLUMINA ss2711132106 Nov 08, 2017 (151)
47 GNOMAD ss2737022388 Nov 08, 2017 (151)
48 GNOMAD ss2748007727 Nov 08, 2017 (151)
49 GNOMAD ss2864092854 Nov 08, 2017 (151)
50 AFFY ss2985433050 Nov 08, 2017 (151)
51 AFFY ss2986076176 Nov 08, 2017 (151)
52 SWEGEN ss3002804432 Nov 08, 2017 (151)
53 ILLUMINA ss3022826073 Nov 08, 2017 (151)
54 ILLUMINA ss3022826074 Nov 08, 2017 (151)
55 CSHL ss3348082024 Nov 08, 2017 (151)
56 ILLUMINA ss3625947308 Oct 12, 2018 (152)
57 ILLUMINA ss3630013637 Oct 12, 2018 (152)
58 ILLUMINA ss3630013638 Oct 12, 2018 (152)
59 ILLUMINA ss3635162175 Oct 12, 2018 (152)
60 ILLUMINA ss3638748368 Oct 12, 2018 (152)
61 ILLUMINA ss3640869465 Oct 12, 2018 (152)
62 ILLUMINA ss3643680166 Oct 12, 2018 (152)
63 ILLUMINA ss3644964714 Oct 12, 2018 (152)
64 ILLUMINA ss3644964715 Oct 12, 2018 (152)
65 ILLUMINA ss3653367027 Oct 12, 2018 (152)
66 ILLUMINA ss3653367028 Oct 12, 2018 (152)
67 ILLUMINA ss3654194864 Oct 12, 2018 (152)
68 EGCUT_WGS ss3670484468 Jul 13, 2019 (153)
69 EVA_DECODE ss3721555439 Jul 13, 2019 (153)
70 ILLUMINA ss3726520351 Jul 13, 2019 (153)
71 ACPOP ss3735467033 Jul 13, 2019 (153)
72 ILLUMINA ss3744302894 Jul 13, 2019 (153)
73 ILLUMINA ss3744577751 Jul 13, 2019 (153)
74 ILLUMINA ss3745461958 Jul 13, 2019 (153)
75 EVA ss3767717753 Jul 13, 2019 (153)
76 PAGE_CC ss3771428683 Jul 13, 2019 (153)
77 ILLUMINA ss3772954551 Jul 13, 2019 (153)
78 EVA ss3824351410 Apr 26, 2020 (154)
79 EVA ss3825737076 Apr 26, 2020 (154)
80 SGDP_PRJ ss3869436715 Apr 26, 2020 (154)
81 EVA ss3985347111 Apr 27, 2021 (155)
82 EVA ss3986415474 Apr 27, 2021 (155)
83 EVA ss4017379939 Apr 27, 2021 (155)
84 TOPMED ss4778093028 Apr 27, 2021 (155)
85 TOMMO_GENOMICS ss5187654418 Apr 27, 2021 (155)
86 EVA ss5237651001 Oct 14, 2022 (156)
87 1000G_HIGH_COVERAGE ss5276330174 Oct 14, 2022 (156)
88 EVA ss5379642199 Oct 14, 2022 (156)
89 HUGCELL_USP ss5472980788 Oct 14, 2022 (156)
90 1000G_HIGH_COVERAGE ss5566254043 Oct 14, 2022 (156)
91 SANFORD_IMAGENETICS ss5624687989 Oct 14, 2022 (156)
92 SANFORD_IMAGENETICS ss5644923846 Oct 14, 2022 (156)
93 TOMMO_GENOMICS ss5729271021 Oct 14, 2022 (156)
94 EVA ss5799434390 Oct 14, 2022 (156)
95 EVA ss5830224465 Oct 14, 2022 (156)
96 EVA ss5848169554 Oct 14, 2022 (156)
97 EVA ss5848702264 Oct 14, 2022 (156)
98 EVA ss5888021520 Oct 14, 2022 (156)
99 EVA ss5974104341 Oct 14, 2022 (156)
100 EVA ss5979856490 Oct 14, 2022 (156)
101 1000Genomes NC_000008.10 - 19813529 Oct 12, 2018 (152)
102 1000Genomes_30x NC_000008.11 - 19956018 Oct 14, 2022 (156)
103 The Avon Longitudinal Study of Parents and Children NC_000008.10 - 19813529 Oct 12, 2018 (152)
104 Genetic variation in the Estonian population NC_000008.10 - 19813529 Oct 12, 2018 (152)
105 ExAC NC_000008.10 - 19813529 Oct 12, 2018 (152)
106 FINRISK NC_000008.10 - 19813529 Apr 26, 2020 (154)
107 The Danish reference pan genome NC_000008.10 - 19813529 Apr 26, 2020 (154)
108 gnomAD - Genomes NC_000008.11 - 19956018 Apr 27, 2021 (155)
109 gnomAD - Exomes NC_000008.10 - 19813529 Jul 13, 2019 (153)
110 Genome of the Netherlands Release 5 NC_000008.10 - 19813529 Apr 26, 2020 (154)
111 HapMap NC_000008.11 - 19956018 Apr 26, 2020 (154)
112 Medical Genome Project healthy controls from Spanish population NC_000008.10 - 19813529 Apr 26, 2020 (154)
113 Northern Sweden NC_000008.10 - 19813529 Jul 13, 2019 (153)
114 The PAGE Study NC_000008.11 - 19956018 Jul 13, 2019 (153)
115 Ancient Sardinia genome-wide 1240k capture data generation and analysis NC_000008.10 - 19813529 Apr 27, 2021 (155)
116 SGDP_PRJ NC_000008.10 - 19813529 Apr 26, 2020 (154)
117 8.3KJPN NC_000008.10 - 19813529 Apr 27, 2021 (155)
118 14KJPN NC_000008.11 - 19956018 Oct 14, 2022 (156)
119 TopMed NC_000008.11 - 19956018 Apr 27, 2021 (155)
120 UK 10K study - Twins NC_000008.10 - 19813529 Oct 12, 2018 (152)
121 ALFA NC_000008.11 - 19956018 Apr 27, 2021 (155)
122 ClinVar RCV000001615.6 Oct 14, 2022 (156)
123 ClinVar RCV000781944.1 Jul 13, 2019 (153)
124 ClinVar RCV000988041.8 Oct 14, 2022 (156)
125 ClinVar RCV001356263.7 Oct 14, 2022 (156)
126 ClinVar RCV002222335.1 Oct 14, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs17850737 Mar 11, 2006 (126)
rs52818902 Sep 21, 2007 (128)
rs386571803 Aug 06, 2014 (136)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
ss93851529, ss206439351, ss217321419, ss217397623, ss217418282, ss244291490, ss491921986, ss1594862271, ss1713021090, ss3643680166 NC_000008.9:19857808:A:G NC_000008.11:19956017:A:G (self)
41009890, 22797095, 16222716, 9205169, 53807, 8758690, 6190779, 10186933, 310464, 8751898, 573038, 21453695, 45623725, 22797095, ss334734988, ss342253784, ss490960919, ss491410891, ss537115398, ss780867933, ss783552867, ss985272617, ss1328915147, ss1582593752, ss1584057346, ss1620133702, ss1663127735, ss1689111573, ss1711194704, ss1752723237, ss1917826322, ss1946231540, ss1946231541, ss1959093877, ss1959093878, ss2024980549, ss2634720445, ss2711132106, ss2737022388, ss2748007727, ss2864092854, ss2985433050, ss2986076176, ss3002804432, ss3022826073, ss3022826074, ss3348082024, ss3625947308, ss3630013637, ss3630013638, ss3635162175, ss3638748368, ss3640869465, ss3644964714, ss3644964715, ss3653367027, ss3653367028, ss3654194864, ss3670484468, ss3735467033, ss3744302894, ss3744577751, ss3745461958, ss3767717753, ss3772954551, ss3824351410, ss3825737076, ss3869436715, ss3985347111, ss3986415474, ss4017379939, ss5187654418, ss5379642199, ss5624687989, ss5644923846, ss5799434390, ss5830224465, ss5848169554, ss5848702264, ss5974104341, ss5979856490 NC_000008.10:19813528:A:G NC_000008.11:19956017:A:G (self)
RCV000001615.6, RCV000781944.1, RCV000988041.8, RCV001356263.7, RCV002222335.1, 53779978, 289194884, 3580981, 650152, 63108125, 615470588, 4798625361, ss244238715, ss252841599, ss2301287943, ss3721555439, ss3726520351, ss3771428683, ss4778093028, ss5237651001, ss5276330174, ss5472980788, ss5566254043, ss5729271021, ss5888021520 NC_000008.11:19956017:A:G NC_000008.11:19956017:A:G (self)
ss268, ss23712753, ss28505039, ss48420135, ss69043148, ss74819581, ss74905524, ss143320833, ss173427532, ss181341869 NT_167187.1:7671674:A:G NC_000008.11:19956017:A:G (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

29 citations for rs268
PMID Title Author Year Journal
8541837 A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Reymer PW et al. 1995 Human molecular genetics
17357073 Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol. Pare G et al. 2007 American journal of human genetics
18280754 Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions. Reiman EM et al. 2008 NeuroImage
18513389 New application of intelligent agents in sporadic amyotrophic lateral sclerosis identifies unexpected specific genetic background. Penco S et al. 2008 BMC bioinformatics
18660489 Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations. Lu Y et al. 2008 Journal of lipid research
18922999 Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. Sagoo GS et al. 2008 American journal of epidemiology
19041386 Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: a systematic in-depth review. Boes E et al. 2009 Experimental gerontology
19131662 A meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Wang X et al. 2009 Stroke
19489872 Association of polymorphisms in genes involved in lipoprotein metabolism with plasma concentrations of remnant lipoproteins and HDL subpopulations before and after hormone therapy in postmenopausal women. Lamon-Fava S et al. 2010 Clinical endocrinology
19501493 A composite scoring of genotypes discriminates coronary heart disease risk beyond conventional risk factors in the Boston Puerto Rican Health Study. Junyent M et al. 2010 Nutrition, metabolism, and cardiovascular diseases
19602472 Lipid and endothelium-related genes, ambient particulate matter, and heart rate variability--the VA Normative Aging Study. Ren C et al. 2010 Journal of epidemiology and community health
20421590 Genetic causes of high and low serum HDL-cholesterol. Weissglas-Volkov D et al. 2010 Journal of lipid research
20429872 Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study. Ariza MJ et al. 2010 BMC medical genetics
20565774 Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project. Cross DS et al. 2010 BMC genetics
20650961 Application of statistical and functional methodologies for the investigation of genetic determinants of coronary heart disease biomarkers: lipoprotein lipase genotype and plasma triglycerides as an exemplar. Smith AJ et al. 2010 Human molecular genetics
21767357 Genetic variants in lipid metabolism are independently associated with multiple features of the metabolic syndrome. Povel CM et al. 2011 Lipids in health and disease
22024213 A novel gene-environment interaction involved in endometriosis. McCarty CA et al. 2012 International journal of gynaecology and obstetrics
22042884 Association of genetic variants and incident coronary heart disease in multiethnic cohorts: the PAGE study. Franceschini N et al. 2011 Circulation. Cardiovascular genetics
22239554 Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. Surendran RP et al. 2012 Journal of internal medicine
22629316 Multi-ethnic analysis of lipid-associated loci: the NHLBI CARe project. Musunuru K et al. 2012 PloS one
24319689 The roles of genetic polymorphisms and human immunodeficiency virus infection in lipid metabolism. de Almeida ER et al. 2013 BioMed research international
25361584 Subgroups at high risk for ischaemic heart disease:identification and validation in 67 000 individuals from the general population. Frikke-Schmidt R et al. 2015 International journal of epidemiology
25474356 Highly significant association between two common single nucleotide polymorphisms in CORIN gene and preeclampsia in Caucasian women. Stepanian A et al. 2014 PloS one
25626708 Resequencing of LPL in African Blacks and associations with lipoprotein-lipid levels. Pirim D et al. 2015 European journal of human genetics
26975783 Meta-analyses of four polymorphisms of lipoprotein lipase associated with the risk of Alzheimer's disease. Ren L et al. 2016 Neuroscience letters
30140409 Lipoprotein lipase gene polymorphisms as risk factors for stroke: a computational and meta-analysis. Nejati M et al. 2018 Iranian journal of basic medical sciences
30333156 Genetic and secondary causes of severe HDL deficiency and cardiovascular disease. Geller AS et al. 2018 Journal of lipid research
32952508 Association of Four Missense SNPs with Preeclampsia in Saudi Women. Aljuaid NM et al. 2020 Saudi journal of medicine & medical sciences
35351696 Empowering consumers to PREVENT diet-related diseases through OMICS sciences (PREVENTOMICS): protocol for a parallel double-blinded randomised intervention trial to investigate biomarker-based nutrition plans for weight loss. Aldubayan MA et al. 2022 BMJ open
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post825+45319f0